Logo
x

Search

Subscribe Now

genfleet

GenFleet Partners with BeiGene to Conduct P-Ib/II Trial of GFH009 and Brukinsa for the Treatment of Diffuse Large B Cell Lymphoma

GenFleet Partners with BeiGene to Conduct P-Ib/II Trial of GFH009 and Brukinsa for the Treatment of Diffuse Large B Cell Lymphoma

  • March 29, 2024
GenFleet Receives EMA Approval to Study GFH925 + Erbitux (cetuximab) as 1L Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer

GenFleet Receives EMA Approval to Study GFH925 + Erbitux (cetuximab) as 1L Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cance...

  • March 2, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.